Review



contractility  (ADInstruments)


Bioz Verified Symbol ADInstruments is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    ADInstruments contractility
    Contractility, supplied by ADInstruments, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/contractility/product/ADInstruments
    Average 94 stars, based on 6 article reviews
    contractility - by Bioz Stars, 2026-05
    94/100 stars

    Images



    Similar Products

    94
    Cytoskeleton Inc contractile actomyosin network
    Contractile Actomyosin Network, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/contractile actomyosin network/product/Cytoskeleton Inc
    Average 94 stars, based on 1 article reviews
    contractile actomyosin network - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    86
    Aurora Scientific vivo muscle contractility system
    ( A ) Schematic representation and images illustrating vasculogenic TNT applied to isografts to induce vascular tissue formation, which guides axonal regeneration, followed by functional outcome measurements over a 13-week period. Segmental nerves (1-cm isografts) from donor mice were dissected, treated with TNT using EFF 1:1:2 or sham, and sutured into the nerve gap of genetically identical recipient mice. Before nerve grafting, TNT was applied to the proximal and distal stumps of the sciatic nerve in the recipient mice. Experimental groups included mice treated with sham or EFF 1:1:2 TNT, grafting without TNT (graft only), mice subjected to a 1-cm graft dissection without repair (cut no repair), and uninjured control mice. ( B ) Hindlimb grip strength significantly increased in the EFF TNT-treated group compared to the sham TNT and graft-only groups, initiating at week 8 and progressing through week 13. The cut no repair group failed to regain strength throughout the 13-week period. ( C ) In vivo muscle <t>contractility</t> assessment showed a significant increase in twitch torque in the EFF TNT group compared to sham TNT group at week 10 and compared to the graft only group at weeks 10 and 13. ( D ) Similarly, the EFF TNT group exhibited a significantly elevated tetanic torque compared to other groups at week 13, further suggesting enhanced muscle recovery and strength ( n = 6 per group). All error bars are shown as SEM. # denotes significant difference with respect to the control, δ denotes significant difference with respect to cut no repair, and * denotes significant difference with respect to another group. δ and * with a P value < 0.05. Two-way ANOVA. Created in BioRender. A. Salazar (2026); https://BioRender.com/yn3s2jn .
    Vivo Muscle Contractility System, supplied by Aurora Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vivo muscle contractility system/product/Aurora Scientific
    Average 86 stars, based on 1 article reviews
    vivo muscle contractility system - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Aurora Scientific muscle contractility apparatus
    ( A ) Schematic representation and images illustrating vasculogenic TNT applied to isografts to induce vascular tissue formation, which guides axonal regeneration, followed by functional outcome measurements over a 13-week period. Segmental nerves (1-cm isografts) from donor mice were dissected, treated with TNT using EFF 1:1:2 or sham, and sutured into the nerve gap of genetically identical recipient mice. Before nerve grafting, TNT was applied to the proximal and distal stumps of the sciatic nerve in the recipient mice. Experimental groups included mice treated with sham or EFF 1:1:2 TNT, grafting without TNT (graft only), mice subjected to a 1-cm graft dissection without repair (cut no repair), and uninjured control mice. ( B ) Hindlimb grip strength significantly increased in the EFF TNT-treated group compared to the sham TNT and graft-only groups, initiating at week 8 and progressing through week 13. The cut no repair group failed to regain strength throughout the 13-week period. ( C ) In vivo muscle <t>contractility</t> assessment showed a significant increase in twitch torque in the EFF TNT group compared to sham TNT group at week 10 and compared to the graft only group at weeks 10 and 13. ( D ) Similarly, the EFF TNT group exhibited a significantly elevated tetanic torque compared to other groups at week 13, further suggesting enhanced muscle recovery and strength ( n = 6 per group). All error bars are shown as SEM. # denotes significant difference with respect to the control, δ denotes significant difference with respect to cut no repair, and * denotes significant difference with respect to another group. δ and * with a P value < 0.05. Two-way ANOVA. Created in BioRender. A. Salazar (2026); https://BioRender.com/yn3s2jn .
    Muscle Contractility Apparatus, supplied by Aurora Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/muscle contractility apparatus/product/Aurora Scientific
    Average 86 stars, based on 1 article reviews
    muscle contractility apparatus - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Aurora Scientific aurora scientific contractile apparatus
    ( A ) Schematic representation and images illustrating vasculogenic TNT applied to isografts to induce vascular tissue formation, which guides axonal regeneration, followed by functional outcome measurements over a 13-week period. Segmental nerves (1-cm isografts) from donor mice were dissected, treated with TNT using EFF 1:1:2 or sham, and sutured into the nerve gap of genetically identical recipient mice. Before nerve grafting, TNT was applied to the proximal and distal stumps of the sciatic nerve in the recipient mice. Experimental groups included mice treated with sham or EFF 1:1:2 TNT, grafting without TNT (graft only), mice subjected to a 1-cm graft dissection without repair (cut no repair), and uninjured control mice. ( B ) Hindlimb grip strength significantly increased in the EFF TNT-treated group compared to the sham TNT and graft-only groups, initiating at week 8 and progressing through week 13. The cut no repair group failed to regain strength throughout the 13-week period. ( C ) In vivo muscle <t>contractility</t> assessment showed a significant increase in twitch torque in the EFF TNT group compared to sham TNT group at week 10 and compared to the graft only group at weeks 10 and 13. ( D ) Similarly, the EFF TNT group exhibited a significantly elevated tetanic torque compared to other groups at week 13, further suggesting enhanced muscle recovery and strength ( n = 6 per group). All error bars are shown as SEM. # denotes significant difference with respect to the control, δ denotes significant difference with respect to cut no repair, and * denotes significant difference with respect to another group. δ and * with a P value < 0.05. Two-way ANOVA. Created in BioRender. A. Salazar (2026); https://BioRender.com/yn3s2jn .
    Aurora Scientific Contractile Apparatus, supplied by Aurora Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aurora scientific contractile apparatus/product/Aurora Scientific
    Average 86 stars, based on 1 article reviews
    aurora scientific contractile apparatus - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    94
    ADInstruments contractility
    ( A ) Schematic representation and images illustrating vasculogenic TNT applied to isografts to induce vascular tissue formation, which guides axonal regeneration, followed by functional outcome measurements over a 13-week period. Segmental nerves (1-cm isografts) from donor mice were dissected, treated with TNT using EFF 1:1:2 or sham, and sutured into the nerve gap of genetically identical recipient mice. Before nerve grafting, TNT was applied to the proximal and distal stumps of the sciatic nerve in the recipient mice. Experimental groups included mice treated with sham or EFF 1:1:2 TNT, grafting without TNT (graft only), mice subjected to a 1-cm graft dissection without repair (cut no repair), and uninjured control mice. ( B ) Hindlimb grip strength significantly increased in the EFF TNT-treated group compared to the sham TNT and graft-only groups, initiating at week 8 and progressing through week 13. The cut no repair group failed to regain strength throughout the 13-week period. ( C ) In vivo muscle <t>contractility</t> assessment showed a significant increase in twitch torque in the EFF TNT group compared to sham TNT group at week 10 and compared to the graft only group at weeks 10 and 13. ( D ) Similarly, the EFF TNT group exhibited a significantly elevated tetanic torque compared to other groups at week 13, further suggesting enhanced muscle recovery and strength ( n = 6 per group). All error bars are shown as SEM. # denotes significant difference with respect to the control, δ denotes significant difference with respect to cut no repair, and * denotes significant difference with respect to another group. δ and * with a P value < 0.05. Two-way ANOVA. Created in BioRender. A. Salazar (2026); https://BioRender.com/yn3s2jn .
    Contractility, supplied by ADInstruments, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/contractility/product/ADInstruments
    Average 94 stars, based on 1 article reviews
    contractility - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    86
    Amgen cardiac contractility
    ( A ) Schematic representation and images illustrating vasculogenic TNT applied to isografts to induce vascular tissue formation, which guides axonal regeneration, followed by functional outcome measurements over a 13-week period. Segmental nerves (1-cm isografts) from donor mice were dissected, treated with TNT using EFF 1:1:2 or sham, and sutured into the nerve gap of genetically identical recipient mice. Before nerve grafting, TNT was applied to the proximal and distal stumps of the sciatic nerve in the recipient mice. Experimental groups included mice treated with sham or EFF 1:1:2 TNT, grafting without TNT (graft only), mice subjected to a 1-cm graft dissection without repair (cut no repair), and uninjured control mice. ( B ) Hindlimb grip strength significantly increased in the EFF TNT-treated group compared to the sham TNT and graft-only groups, initiating at week 8 and progressing through week 13. The cut no repair group failed to regain strength throughout the 13-week period. ( C ) In vivo muscle <t>contractility</t> assessment showed a significant increase in twitch torque in the EFF TNT group compared to sham TNT group at week 10 and compared to the graft only group at weeks 10 and 13. ( D ) Similarly, the EFF TNT group exhibited a significantly elevated tetanic torque compared to other groups at week 13, further suggesting enhanced muscle recovery and strength ( n = 6 per group). All error bars are shown as SEM. # denotes significant difference with respect to the control, δ denotes significant difference with respect to cut no repair, and * denotes significant difference with respect to another group. δ and * with a P value < 0.05. Two-way ANOVA. Created in BioRender. A. Salazar (2026); https://BioRender.com/yn3s2jn .
    Cardiac Contractility, supplied by Amgen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cardiac contractility/product/Amgen
    Average 86 stars, based on 1 article reviews
    cardiac contractility - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc cardiac contractility phospholamban
    ( A ) Schematic representation and images illustrating vasculogenic TNT applied to isografts to induce vascular tissue formation, which guides axonal regeneration, followed by functional outcome measurements over a 13-week period. Segmental nerves (1-cm isografts) from donor mice were dissected, treated with TNT using EFF 1:1:2 or sham, and sutured into the nerve gap of genetically identical recipient mice. Before nerve grafting, TNT was applied to the proximal and distal stumps of the sciatic nerve in the recipient mice. Experimental groups included mice treated with sham or EFF 1:1:2 TNT, grafting without TNT (graft only), mice subjected to a 1-cm graft dissection without repair (cut no repair), and uninjured control mice. ( B ) Hindlimb grip strength significantly increased in the EFF TNT-treated group compared to the sham TNT and graft-only groups, initiating at week 8 and progressing through week 13. The cut no repair group failed to regain strength throughout the 13-week period. ( C ) In vivo muscle <t>contractility</t> assessment showed a significant increase in twitch torque in the EFF TNT group compared to sham TNT group at week 10 and compared to the graft only group at weeks 10 and 13. ( D ) Similarly, the EFF TNT group exhibited a significantly elevated tetanic torque compared to other groups at week 13, further suggesting enhanced muscle recovery and strength ( n = 6 per group). All error bars are shown as SEM. # denotes significant difference with respect to the control, δ denotes significant difference with respect to cut no repair, and * denotes significant difference with respect to another group. δ and * with a P value < 0.05. Two-way ANOVA. Created in BioRender. A. Salazar (2026); https://BioRender.com/yn3s2jn .
    Cardiac Contractility Phospholamban, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cardiac contractility phospholamban/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    cardiac contractility phospholamban - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    86
    Galectin Therapeutics galectin 3 inhibits cardiac contractility via a tumor necrosis factor alpha dependent mechanism in cirrhotic rats
    ( A ) Schematic representation and images illustrating vasculogenic TNT applied to isografts to induce vascular tissue formation, which guides axonal regeneration, followed by functional outcome measurements over a 13-week period. Segmental nerves (1-cm isografts) from donor mice were dissected, treated with TNT using EFF 1:1:2 or sham, and sutured into the nerve gap of genetically identical recipient mice. Before nerve grafting, TNT was applied to the proximal and distal stumps of the sciatic nerve in the recipient mice. Experimental groups included mice treated with sham or EFF 1:1:2 TNT, grafting without TNT (graft only), mice subjected to a 1-cm graft dissection without repair (cut no repair), and uninjured control mice. ( B ) Hindlimb grip strength significantly increased in the EFF TNT-treated group compared to the sham TNT and graft-only groups, initiating at week 8 and progressing through week 13. The cut no repair group failed to regain strength throughout the 13-week period. ( C ) In vivo muscle <t>contractility</t> assessment showed a significant increase in twitch torque in the EFF TNT group compared to sham TNT group at week 10 and compared to the graft only group at weeks 10 and 13. ( D ) Similarly, the EFF TNT group exhibited a significantly elevated tetanic torque compared to other groups at week 13, further suggesting enhanced muscle recovery and strength ( n = 6 per group). All error bars are shown as SEM. # denotes significant difference with respect to the control, δ denotes significant difference with respect to cut no repair, and * denotes significant difference with respect to another group. δ and * with a P value < 0.05. Two-way ANOVA. Created in BioRender. A. Salazar (2026); https://BioRender.com/yn3s2jn .
    Galectin 3 Inhibits Cardiac Contractility Via A Tumor Necrosis Factor Alpha Dependent Mechanism In Cirrhotic Rats, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/galectin 3 inhibits cardiac contractility via a tumor necrosis factor alpha dependent mechanism in cirrhotic rats/product/Galectin Therapeutics
    Average 86 stars, based on 1 article reviews
    galectin 3 inhibits cardiac contractility via a tumor necrosis factor alpha dependent mechanism in cirrhotic rats - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Schematic representation and images illustrating vasculogenic TNT applied to isografts to induce vascular tissue formation, which guides axonal regeneration, followed by functional outcome measurements over a 13-week period. Segmental nerves (1-cm isografts) from donor mice were dissected, treated with TNT using EFF 1:1:2 or sham, and sutured into the nerve gap of genetically identical recipient mice. Before nerve grafting, TNT was applied to the proximal and distal stumps of the sciatic nerve in the recipient mice. Experimental groups included mice treated with sham or EFF 1:1:2 TNT, grafting without TNT (graft only), mice subjected to a 1-cm graft dissection without repair (cut no repair), and uninjured control mice. ( B ) Hindlimb grip strength significantly increased in the EFF TNT-treated group compared to the sham TNT and graft-only groups, initiating at week 8 and progressing through week 13. The cut no repair group failed to regain strength throughout the 13-week period. ( C ) In vivo muscle contractility assessment showed a significant increase in twitch torque in the EFF TNT group compared to sham TNT group at week 10 and compared to the graft only group at weeks 10 and 13. ( D ) Similarly, the EFF TNT group exhibited a significantly elevated tetanic torque compared to other groups at week 13, further suggesting enhanced muscle recovery and strength ( n = 6 per group). All error bars are shown as SEM. # denotes significant difference with respect to the control, δ denotes significant difference with respect to cut no repair, and * denotes significant difference with respect to another group. δ and * with a P value < 0.05. Two-way ANOVA. Created in BioRender. A. Salazar (2026); https://BioRender.com/yn3s2jn .

    Journal: Science Advances

    Article Title: Vasculogenic tissue nanotransfection accelerates functional recovery after peripheral nerve injury

    doi: 10.1126/sciadv.aeb7631

    Figure Lengend Snippet: ( A ) Schematic representation and images illustrating vasculogenic TNT applied to isografts to induce vascular tissue formation, which guides axonal regeneration, followed by functional outcome measurements over a 13-week period. Segmental nerves (1-cm isografts) from donor mice were dissected, treated with TNT using EFF 1:1:2 or sham, and sutured into the nerve gap of genetically identical recipient mice. Before nerve grafting, TNT was applied to the proximal and distal stumps of the sciatic nerve in the recipient mice. Experimental groups included mice treated with sham or EFF 1:1:2 TNT, grafting without TNT (graft only), mice subjected to a 1-cm graft dissection without repair (cut no repair), and uninjured control mice. ( B ) Hindlimb grip strength significantly increased in the EFF TNT-treated group compared to the sham TNT and graft-only groups, initiating at week 8 and progressing through week 13. The cut no repair group failed to regain strength throughout the 13-week period. ( C ) In vivo muscle contractility assessment showed a significant increase in twitch torque in the EFF TNT group compared to sham TNT group at week 10 and compared to the graft only group at weeks 10 and 13. ( D ) Similarly, the EFF TNT group exhibited a significantly elevated tetanic torque compared to other groups at week 13, further suggesting enhanced muscle recovery and strength ( n = 6 per group). All error bars are shown as SEM. # denotes significant difference with respect to the control, δ denotes significant difference with respect to cut no repair, and * denotes significant difference with respect to another group. δ and * with a P value < 0.05. Two-way ANOVA. Created in BioRender. A. Salazar (2026); https://BioRender.com/yn3s2jn .

    Article Snippet: For muscle contractility testing, mice were placed in a supine position on the platform to first assess the right hindlimb using an in vivo muscle contractility system (Aurora Scientific Inc., Canada Model 1300A Muscle).

    Techniques: Functional Assay, Dissection, Control, In Vivo